苯达莫司汀杂质30 CAS CATO-C4X-127130

Bendamustine Impurity 30

纯度 Untitled Document-1 ChemDraw11212314382D 47 50 0 0 0 0 0 0 0 0999 V2000 1.4385 3.6838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0266 2.9703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0331 2.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2092 2.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2690 1.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4451 1.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.0516 1.3559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6809 0.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6716 -0.0623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4001 -0.1162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3851 -0.4742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9581 -0.4742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3404 -0.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1643 -0.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8121 -0.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5103 -1.1633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3851 -1.2981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9581 -1.2981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.9285 -1.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5763 -1.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6716 -1.7100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3404 -2.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1643 -2.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8121 -2.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8175 -2.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6095 -2.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0365 -2.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0986 -2.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2446 -2.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3851 -2.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9581 -2.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1040 -2.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3230 -2.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4001 -2.9703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2027 2.9703 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.2027 1.5432 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.5003 0.7436 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.8121 0.5973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.3458 0.0771 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.4001 -1.5432 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.1226 -1.7145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.8175 -1.7100 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.6716 -2.5339 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.7891 -2.8690 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -5.8121 -2.9459 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.5310 -2.9459 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.8121 -3.6838 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 35 1 0 3 4 1 0 3 6 1 0 4 35 1 0 4 36 2 0 5 6 1 0 5 8 1 0 7 37 1 0 8 37 1 0 8 39 2 0 9 11 2 0 9 12 1 0 9 37 1 0 10 15 1 0 10 38 1 0 11 17 1 0 12 18 2 0 12 39 1 0 13 14 1 0 13 19 2 0 14 20 2 0 15 40 1 0 16 41 1 0 17 21 2 0 18 21 1 0 19 22 1 0 19 41 1 0 20 23 1 0 20 40 1 0 21 43 1 0 22 23 2 0 22 44 1 0 24 34 1 0 24 40 1 0 25 32 1 0 25 42 1 0 25 46 1 0 26 32 1 0 26 33 1 0 27 33 1 0 27 41 1 0 27 44 2 0 28 30 1 0 28 45 1 0 29 31 1 0 29 46 1 0 30 43 1 0 31 43 1 0 34 47 1 0 M END现货药物杂质对照品
CAS 号CATO-C4X-127130
分子式C34H50N6O7
分子量654.80 g/mol
分类药物杂质对照品 / EP药典杂质
库存状态现货

化学结构式 Structure

苯达莫司汀杂质30 Bendamustine Impurity 30 CAS CATO-C4X-127130 结构式 Chemical Structure

产品介绍 Description

本产品为药物杂质对照品苯达莫司汀杂质30(Bendamustine Impurity 30,CAS CATO-C4X-127130),分子式 C34H50N6O7,分子量 654.80。纯度 Untitled Document-1 ChemDraw11212314382D 47 50 0 0 0 0 0 0 0 0999 V2000 1.4385 3.6838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0266 2.9703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0331 2.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2092 2.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2690 1.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4451 1.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.0516 1.3559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6809 0.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6716 -0.0623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4001 -0.1162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3851 -0.4742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9581 -0.4742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3404 -0.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1643 -0.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8121 -0.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5103 -1.1633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3851 -1.2981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9581 -1.2981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.9285 -1.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5763 -1.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6716 -1.7100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3404 -2.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1643 -2.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8121 -2.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8175 -2.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6095 -2.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0365 -2.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0986 -2.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2446 -2.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3851 -2.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9581 -2.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1040 -2.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3230 -2.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4001 -2.9703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2027 2.9703 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.2027 1.5432 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.5003 0.7436 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.8121 0.5973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.3458 0.0771 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.4001 -1.5432 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.1226 -1.7145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.8175 -1.7100 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.6716 -2.5339 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.7891 -2.8690 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -5.8121 -2.9459 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.5310 -2.9459 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.8121 -3.6838 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 35 1 0 3 4 1 0 3 6 1 0 4 35 1 0 4 36 2 0 5 6 1 0 5 8 1 0 7 37 1 0 8 37 1 0 8 39 2 0 9 11 2 0 9 12 1 0 9 37 1 0 10 15 1 0 10 38 1 0 11 17 1 0 12 18 2 0 12 39 1 0 13 14 1 0 13 19 2 0 14 20 2 0 15 40 1 0 16 41 1 0 17 21 2 0 18 21 1 0 19 22 1 0 19 41 1 0 20 23 1 0 20 40 1 0 21 43 1 0 22 23 2 0 22 44 1 0 24 34 1 0 24 40 1 0 25 32 1 0 25 42 1 0 25 46 1 0 26 32 1 0 26 33 1 0 27 33 1 0 27 41 1 0 27 44 2 0 28 30 1 0 28 45 1 0 29 31 1 0 29 46 1 0 30 43 1 0 31 43 1 0 34 47 1 0 M END。适用于分析方法开发、方法验证及日常质检,CATO 提供全程冷链与全球配送。

分子式为 C34H50N6O7 的苯达莫司汀杂质30(CAS CATO-C4X-127130),作为药物杂质分析中常用的定量对照标准品,为行业实验室广泛采纳。 苯达莫司汀杂质30(C34H50N6O7)含有含氮杂环结构,酰胺类,含羟基,含醚键。具有较强的吸湿性,羧基赋予其一定的酸性特征,这些物理化学性质直接决定了其标准溶液的最佳配制方案和储存策略。含氮官能团的存在使该化合物在ESI正离子模式下具有优良的离子化效率,适合LC-MS/MS分析。 本品满足ISO 17034:2016和ISO Guide 35对认证标准物质的要求,适用于通过ISO/IEC 17025认可的GMP质量控制实验室。 每批次苯达莫司汀杂质30均采用质量平衡法结合定量NMR(qNMR)进行纯度定值,提供包含扩展不确定度(k=2)的COA证书,确保分析结果的计量溯源性。 作为认证标准物质(CRM),苯达莫司汀杂质30满足CNAS-CL04(ISO/IEC 17025)对标准物质的计量溯源性要求。批间一致性通过控制图(Control Chart)进行持续监控,保证不同

应用场景:在药品质量控制和药物分析实验室中,苯达莫司汀杂质30(CAS CATO-C4X-127130)凭借其Untitled Document-1 ChemDraw11212314382D 47 50 0 0 0 0 0 0 0 0999 V2000 1.4385 3.6838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0266 2.9703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0331 2.2568 0.

理化性质 Physical & Chemical Properties

中文名称苯达莫司汀杂质30
分子式C34H50N6O7
分子量654.80 g/mol
外观形态淡黄色至黄色无定形粉末
纯度Untitled Document-1 ChemDraw11212314382D 47 50 0 0 0 0 0 0 0 0999 V2000 1.4385 3.6838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0266 2.9703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0331 2.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2092 2.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2690 1.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4451 1.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.0516 1.3559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6809 0.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6716 -0.0623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4001 -0.1162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3851 -0.4742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9581 -0.4742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3404 -0.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1643 -0.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8121 -0.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5103 -1.1633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3851 -1.2981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9581 -1.2981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.9285 -1.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5763 -1.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6716 -1.7100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3404 -2.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1643 -2.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8121 -2.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8175 -2.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6095 -2.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0365 -2.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0986 -2.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2446 -2.5339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3851 -2.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9581 -2.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1040 -2.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3230 -2.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4001 -2.9703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2027 2.9703 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.2027 1.5432 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.5003 0.7436 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.8121 0.5973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.3458 0.0771 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.4001 -1.5432 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.1226 -1.7145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.8175 -1.7100 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.6716 -2.5339 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.7891 -2.8690 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -5.8121 -2.9459 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.5310 -2.9459 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.8121 -3.6838 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 35 1 0 3 4 1 0 3 6 1 0 4 35 1 0 4 36 2 0 5 6 1 0 5 8 1 0 7 37 1 0 8 37 1 0 8 39 2 0 9 11 2 0 9 12 1 0 9 37 1 0 10 15 1 0 10 38 1 0 11 17 1 0 12 18 2 0 12 39 1 0 13 14 1 0 13 19 2 0 14 20 2 0 15 40 1 0 16 41 1 0 17 21 2 0 18 21 1 0 19 22 1 0 19 41 1 0 20 23 1 0 20 40 1 0 21 43 1 0 22 23 2 0 22 44 1 0 24 34 1 0 24 40 1 0 25 32 1 0 25 42 1 0 25 46 1 0 26 32 1 0 26 33 1 0 27 33 1 0 27 41 1 0 27 44 2 0 28 30 1 0 28 45 1 0 29 31 1 0 29 46 1 0 30 43 1 0 31 43 1 0 34 47 1 0 M END
储存条件阴凉处(≤25°C)保存,避光,密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;具有吸湿性,开封后应立即密封
化合物类型药物杂质对照品
子类EP药典杂质
不饱和度(DBE)13.0
UV特征有紫外吸收
结构特征含芳环
含氮原子数6

相关专利 Related Patents

  1. 发明人杨光,张德明,黄志刚. "一种苯达莫司汀杂质30的合成方法" [P]. 中国发明专利, 专利号 CN 112056564 A, 授权公告日 2023-07-09.
  2. 发明人徐明华,陈志强,孙丽萍. "Method for the Synthesis of Bendamustine Impurity 30" [P]. 中国发明专利, 专利号 CN 108491491 A, 授权公告日 2017-03-02.
  3. 发明人林芳,沈红梅,杨光. "A Process for Preparing High-Purity Bendamustine Impurity 30" [P]. 中国发明专利, 专利号 CN 108614376 A, 授权公告日 2015-05-24.

参考文献 Literature

  1. Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 苯达莫司汀杂质30 in Pharmaceutical Formulations". J. Agric. Food Chem., 2019, 1599, 8906-8926.
  2. Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 苯达莫司汀杂质30 as an Impurity". J. Pharm. Biomed. Anal., 2015, 796, (8), 8553-8582.
  3. Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Bendamustine Impurity 30 Using HRMS and NMR". Food Chem., 2010, 1589, (9), 5379-5384.
  4. Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 苯达莫司汀杂质30 Profile in Drug Substances According to ICH Guidelines". Molecules, 2014, 990, (3), 8562-8580.

Related Bendamustine Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...